Clinical Trials Directory

Trials / Conditions / Thyroid Gland Medullary Carcinoma

Thyroid Gland Medullary Carcinoma

16 registered clinical trials studyying Thyroid Gland Medullary Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog
NCT07118176
Jonsson Comprehensive Cancer CenterPhase 1
Active Not RecruitingSelpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
M.D. Anderson Cancer CenterPhase 2
RecruitingPatient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials
NCT03892993
M.D. Anderson Cancer CenterN/A
Active Not RecruitingCabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi
NCT02867592
National Cancer Institute (NCI)Phase 2
CompletedEffect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metasta
NCT02592356
M.D. Anderson Cancer CenterN/A
Active Not RecruitingCopper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NCT02293954
City of Hope Medical CenterN/A
CompletedCabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
NCT01709435
National Cancer Institute (NCI)Phase 1
CompletedCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N
NCT01204476
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedSunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
NCT00519896
University of WashingtonPhase 2
CompletedSuberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurr
NCT00134043
National Cancer Institute (NCI)Phase 2
CompletedEverolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
NCT00655655
Mayo ClinicPhase 1
CompletedTanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
NCT00118248
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can
NCT00068497
National Cancer Institute (NCI)N/A
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1